The US has approved Novartis therapy for prostate cancer

The US Food and Drug Administration has approved Novartis AG therapy for the treatment of patients with advanced prostate cancer that has spread to other parts of the body, the drugmaker said.

Share this post:

Related Posts
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore
WordPress Cookie Plugin by Real Cookie Banner